Exousia Bio, Inc.
Close on Oct 19, 2026
- Market cap
- $175.47K
- P/E (TTM)
- –
- Dividend yield
- –
About Exousia Bio
Services-Educational Services, SIC 8200
LAMY is an early-stage company developing educational products that combine eLearning and gaming. The business focuses on teaching financial principles and resource management to children through an educational platform and a video game marketed as twoplus1®. Designed to operate on a subscription model, the gaming product offers interactive instruction in finance and real estate, including features that allow participants to trade virtual properties and generate transaction commissions.
The company operates on a small scale as a startup with limited operations and maintains intellectual property protection for its brand in the United Kingdom while pursuing coverage in other regions. It has leased executive offices situated in New York City, New York.
Summary of the business section of Exousia Bio's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Exousia Bio, Inc.
- Founded
- 2022
- Headquarters
- St. Petersburg, FL
- Address
- 7901 4th Street N #23494 33702
- Phone
- (940) 367-6154
- Industry
- Services-Educational Services
- Incorporated in
- WY
- Fiscal year ends
- May 31
- Auditor
- BOLADALE LAWAL & CO., Lagos, Nigeria
Stock & identifiers
- Ticker
- LMMY
- Exchange
- OTC
- IPO date
- Oct 1, 2024
- Shares outstanding
- 53M, Jun 15, 2026
- Public float
- $1.29M, Nov 30, 2024
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1939937
- EIN
- 37-2039216
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Exousia Bio's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 31, 2026 | Deregistration | Termination of SEC registration (Form 15) |
| Apr 14, 2026 | Late filing | Notification of late filing |
| Jan 15, 2026 | Late filing | Notification of late filing |
| Jan 15, 2026 | Name change | Name changed from LAMY to Exousia Bio, Inc. |
| Nov 17, 2025 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Oct 16, 2025 | Late filing | Notification of late filing |
| Aug 29, 2025 | Late filing | Notification of late filing |
| Apr 14, 2025 | Late filing | Notification of late filing |
| Aug 30, 2024 | Late filing | Notification of late filing |
| Aug 29, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |